Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -7.18% vs 3.46% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -13.90% vs -42.15% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -16.83% vs -16.28% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 5.74% vs -36.79% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Regeneron Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -7.18% vs 3.46% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 19.04% vs -3.70% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -13.90% vs -42.15% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -10.08% vs 12.01% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -16.83% vs -16.28% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 18.76% vs -16.24% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 5.74% vs -36.79% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 48.28% vs -45.96% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






